Skip to main content

Aeterna Zentaris(AEZS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults

Globe Newswire - Tue Apr 19, 2022

Strengthens intellectual property portfolio for macimorelinand thecommercial product Ghryvelin®/Macrilenin Europe as the Company plans to pursue even greater protection

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe